Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 4, 2002, Pages 577-583

  Ueyama, Y ^a   Monden, Y ^a   He, X B ^a   Lin, C X ^a   Momen, M A ^a   Mimura, S ^a   Umemoto, Atsushi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

ACF; Bile acid; DNA adduct; PhIP; Rat colon

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; BILE ACID; DEOXYCHOLIC ACID; DNA; URSODEOXYCHOLIC ACID;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA ADDUCT; GENE MUTATION; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; CARCINOGENS; COLON; DEOXYCHOLIC ACID; DNA ADDUCTS; IMIDAZOLES; INTESTINAL MUCOSA; MALE; PLATELET ACTIVATING FACTOR; RATS; RATS, INBRED F344; URSODEOXYCHOLIC ACID;

EID: 0036996155     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Reddy B.S., Engle A., Simi B., Goldman M.: Effect of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. Gastroenterology 102: 1475-1482, 1992.
2. Reddy B., Engle A., Katsifis S. et al.: Biochemical epidemiology of colon cancer: effect of types of dietary fiber on fecal mutagens, acid, and neutral sterols in healthy subjects. Cancer Res. 49: 4629-4635, 1989.
3. DeRubertus F.R., Craven P.A., Saito R.: Bile salt stimulation of colonic epithelial proliferation: evidence for involvement of lipoxygenase products. J. Clin. Invest. 74: 1614-1624, 1984.
4. Reddy B.S., Wynder E.L.: Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer 39: 2533-2539, 1977.
5. Weisburger J.H., Wynder E.L., Horn C.L.: Nutritional factors and etiologic mechanisms in the causation of gastrointestinal cancers. Cancer 50(11 Suppl): 2541-2549, 1982.
6. Bird R.P.: Observation and quantitation of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett. 37: 147-151, 1987.
7. Pretlow T.P., Barrow B.J., Ashton W.S. et al.: Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 51: 1564-1567, 1991.
8. Siu I.M., Robinson D.R., Schwartz S. et al.: The identification of monoclonality in human aberrant crypt foci. Cancer Res. 59: 63-66, 1999.
9. Jen J., Powell S.M., Papadopoulos N. et al.: Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54: 5523-5526, 1994.
10. Hardman W.E., Cameron I.L., Heitman D.W., Contreras E.: Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidence. Cancer Res. 51: 6388-6392, 1991.
11. Carter J.W., Lancaster H.K., Hardman W.E., Cameron I.L.: Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res. 54: 4304-4307, 1994.
12. Yamada Y., Yoshimi N., Hirose Y. et al.: Frequent b-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res. 60: 3323-3327, 2000.
13. Yamada Y., Yoshimi N., Hirose Y. et al.: Sequential analysis of morphological and biological properties of b-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res. 61: 1874-1878, 2001.
14. Magnuson B.A., Bird R.P.: Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Lett. 68: 15-23, 1993.
15. Magnuson B.A., Carr I., Bird R.P.: Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res. 53: 4499-4504, 1993.
16. Sutherland L.A., Bird R.P.: The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. Cancer Lett. 76: 101-107, 1994.
17. Baijal P.K., Fitzpatrick D.W., Bird R.P.: Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis. Nutr. Cancer 31: 81-89, 1998.
18. Seraj M.J., Umemoto A., Kajikawa A. et al.: Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats. Cancer Lett. 115: 97-103, 1997.
19. Lin C.X., Umemoto A., Seraj M.J., Mimura S., Monden Y.: Effect of bile acid on formation of azoxymethane-induced aberrant crypt foci in colostomized F344 rat colon. Cancer Lett. 169: 121-126, 2001.
20. Wakabayashi K., Nagao M., Esumi H., Sugimura T.: Food-derived mutagens and carcinogenesis. Cancer Res. 52(Supple.): 2092s-2098s, 1992.
21. Skog K., Knize M.G., Felton J.S., Jagerstad M.: Formation of new heterocyclic amine mutagens by heating creatinine, alanine, threonine and glucose. Mutat. Res. 268: 191-197, 1992.
22. Ito N., Hasegawa R., Sano M. et al.: A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 12: 1503-1506, 1991.
23. Nagao M., Ushijima T., Toyota M., Inoue R., Sugimura T.: Genetic changes induced by heterocyclic amines. Mutat. Res. 376: 161-167, 1997.
24. Takahashi S., Ogawa K., Ohshima H., Esumi H., Ito N., Sugimura T.: Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 82: 135-137, 1991.
25. Umemoto A., Kajikawa A., Tanaka M. et al.: Presence of mucosa-specific DNA adduct in human colon: possible implication for colorectal cancer. Carcinogenesis 15: 901-905, 1994.
26. Reddy M.V., Randerath K.: Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7: 1543-1551, 1986.
27. Jacoby R.F., Llor X., Teng B.B., Davidson N.O., Brasitus T.A.: Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J. Clin. Invest. 87: 624-630, 1991.
28. Takahashi M., Fukuda K., Sugimura T., Wakabayashi K.: bcatenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res. 58: 42-46, 1998.
29. Dashwood R.H., Suzui M., Nakagami H., Sugimura T., Nagao M.: High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res. 58: 1127-1129, 1998.
30. Reddy B.S., Simi B., Patel N., Aliaga C., Rao C.V.: Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion. Cancer Res. 56: 2314-2320, 1996.
31. Wali R.K., Frawley B.P. Jr., Hartmann S. et al.: Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta. Cancer Res. 55: 5257-5264, 1995.
32. Brady L.M., Beno D.W., Davis B.H.: Bile acid stimulation of early growth response gene and mitogen-activated protein kinase is protein kinase C-dependent. Biochem. J. 316: 765-769, 1996.
33. Zhang F., Subbaramaiah K., Altorki N., Dannenberg A.J.: Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J. Biol. Chem. 273: 2424-2428, 1998.
34. Makishima M., Okamoto A.Y., Repa J.J. et al.: Identification of a nuclear receptor for bile acids. Science 284: 1362-1365, 1999.
35. Parks D.J., Blanchard S.G., Bledsoe R.K. et al.: Bile acids: natural ligands for an orphan nuclear receptor. Science 284: 1365-1368, 1999.
36. Tsukamoto T., Tanaka H., Fukami H. et al.: More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP)-treated rats. Jpn. J. Cancer Res. 91: 792-796, 2000.
37. Venitt S., Bosworth D., Easton D.F.: Lack of mutagenic activity of bile acids in bacterial fluctuation tests. Mutat. Res. 191: 129-131, 1987.
38. Koutsos M.I., Shiff S.J., Rigas B.: The effect of ursodeoxycholic and lithocholic acid on cell cycle and apoptosis in human colon adenocarcinoma cells. Gastroenterology 108: A492, 1995.
39. Martinez J.D., Stratagoules E.D., LaRue J.M. et al.: Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr. Cancer 31: 111-118, 1998.
40. Suaeyun R., Kinouchi T., Arimochi H., Vinitketkumnuen U., Ohnishi Y.: Inhibitory effects of lemon grass (Cymbopogon citratus Stapf) on formation of azoxymethane-induced DNA adducts and aberrant crypt foci in the rat colon. Carcinogenesis 18: 949-955, 1997.
41. Ogawa A., Murate T., Suzuki M., Nimura Y., Yoshida S.: Lithocholic acid, a putative tumor promoter, inhibits mammalian DNA polymesase beta. Jpn. J. Cancer Res. 89: 1154-1159, 1998.
42. Breuer N.F., Rampton D.S., Tammar A., Murphy G.M., Dowling R.H.: Effect of colonic perfusion with sulfated and nonsulfated bile acids on mucosal structure and function in the rat. Gastroenterology 84: 969-977, 1983.